Decagon Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Decagon Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Buy	162,702 +15,200	+10%	+$11.9K	0.03%	42
2025 Q4	$105K	Sell	147,502 -45,122	-23%	-$37.7K	0.04%	32
2025 Q3	$144K	Buy	192,624 +7,877	+4%	+$6.37K	0.07%	34
2025 Q2	$162K	Buy	184,747 +3,305	+2%	+$2.55K	0.11%	29
2025 Q1	$136K	Sell	181,442 -544	-0.3%	-$413	0.1%	26
2024 Q4	$160K	Buy	+181,986	New	+$119K	0.07%	24

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Decagon Asset Management's OACCW Position: Q1 2026 in Review

Decagon Asset Management increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 10% in Q1 2026, buying an estimated $11.9K and bringing the position to 162,702 shares worth $122K. The position accounts for 0.03% of the portfolio, ranked #42.

Decagon Asset Management first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $162K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

Decagon Asset Management held 162,702 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $122K as of Q1 2026.
Decagon Asset Management bought 15,200 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $11.9K.
Oaktree Acquisition Corp III Life Sciences Warrant made up 0.03% of Decagon Asset Management's portfolio in Q1 2026, its #42 holding.
Decagon Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
Decagon Asset Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $162K in Q2 2025.
26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Decagon Asset Management's 13F filing for Q1 2026, filed 15 May 2026.